ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "lupus nephritis and rituximab"

  • Abstract Number: 2932 • ACR/ARHP Annual Meeting 2015

    A Retrospective Observational Study of Patients with Lupus Nephritis Treated with Rituximab in Combination with Cyclophosphamide

    Nídia Oliveira1, Mónica Ibañez2, Natalia Ciang3 and David A. Isenberg4, 1Internal Medicine Department, Hospital Pedro Hispano, Matosinhos, Portugal, London, United Kingdom, 2Rheumatology Department, Hospital Son Llàtzer, Palma de Mallorca, Spain, London, United Kingdom, 3Rheumatology Department, Queen Eliazbeth Hospital, Hong Kong, London, United Kingdom, 4Rayne Institute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom

    Background/Purpose: Lupus nephritis (LN) is a major cause of morbidity. Many patients with refractory disease can not tolerate conventional immunosuppressive therapy. The aims of this…
  • Abstract Number: 588 • ACR/ARHP Annual Meeting 2013

    Efficacy Of Rituximab In Patients With Refractory Lupus Nephritis, a Post-Hoc Analysis From Phase II Trial In Japan

    Yoshiya Tanaka1, Kazuhiko Yamamoto2, Tsutomu Takeuchi3, Nobuyuki Miyasaka4, Takayuki Sumida5, Tsuneyo Mimori6, Takao Koike7 and Kazuhiro Endo8, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2Department of Allergy and Rhaumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 3Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 4Tokyo Medical and Dental University, Tokyo, Japan, 5Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 6Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 7Rheumatology, NTT Sapporo Medical Center, Sapporo, Japan, 8Clinical Development, Zenyaku Kogyo Co., Ltd., Tokyo, Japan

    Background/Purpose: B-cell depletion therapy by rituximab has been reported to be useful for treatment of lupus nephritis (LN) in many observational uncontrolled studies, however, placebo-controlled…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology